Dinh Hieu Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dinh Hieu Nguyen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Eric Boulanger
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167—RID-AGE
3 shared publications - Frédéric Jacques Tessier
U1167-RID-AGE-Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, Institut Pasteur de Lille, University Lille, Inserm, CHU Lille, F-59000 Lille, France
3 shared publications - Michael Howsam
Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, UMR 1167 - RID-AGE, F-59000 Lille, France
3 shared publications - Catherine Helmer
University of Bordeaux, INSERM, BPH, U1219, France
2 shared publications - Cécile Delcourt
Univ. Bordeaux, INSERM, BPH, Bordeaux, France
2 shared publications - Kamel Mohammedi
Endocrine department, University Hospital of Bordeaux, Bordeaux, France
2 shared publications
Latest Publications
- 11 August 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 593
Determination of pentosidine in fingernails by liquid chromatography with fluorescence detection (LC-FL) – Methodology and association with glycated hemoglobin (HbA1c), skin autofluorescence (SAF) and other ungual glycation biomarkers among people with diabetes.
- 11 August 2026
- Published by Elsevier in Clinica Chimica Acta
- Vol. 593
Determination of pentosidine in fingernails by liquid chromatography with fluorescence detection (LC-FL) – Methodology and association with glycated hemoglobin (HbA1c), skin autofluorescence (SAF) and other ungual glycation biomarkers among people with diabetes.
- 10 April 2026
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 63 (7) , 621-649
Glycation and disease: a systematic review of the analytical methods and applications of advanced glycation end products (AGEs) as biomarkers of disease
Over a century since Louis Camille Maillard first described the reaction that bears his name, advanced glycation end products (AGEs) resulting from the advanced stage of the glycation reaction have been widely implicated in the onset and progression of various non-communicable diseases. Although a number of studies on the relationship of AGEs with various diseases have been published, none of them to date has comprehensively and critically assessed the quantification of specific AGEs alongside a description of the analytical methods employed and their clinical relevance as biomarkers. We here provide a review of 116 pertinent articles from the last 10 years and describe the analytical methods, the matrices investigated, and the findings related to specific glycation biomarkers in relation to diagnosis or prognosis of disease-in particular diabetes and its complications, but also cardiovascular and renal diseases, as well as other conditions. Significant trends from the last decade are the diversification of applications beyond diabetes and its complications, an increasing number of innovative, noninvasive approaches to quantifying glycation biomarkers which seek to facilitate large-scale screening and early intervention, and the emergence of approaches combining several markers into a suite of analytes for assessment using Z-scores or machine learning algorithms.
- 10 April 2026
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 63 (7) , 621-649
Glycation and disease: a systematic review of the analytical methods and applications of advanced glycation end products (AGEs) as biomarkers of disease
Over a century since Louis Camille Maillard first described the reaction that bears his name, advanced glycation end products (AGEs) resulting from the advanced stage of the glycation reaction have been widely implicated in the onset and progression of various non-communicable diseases. Although a number of studies on the relationship of AGEs with various diseases have been published, none of them to date has comprehensively and critically assessed the quantification of specific AGEs alongside a description of the analytical methods employed and their clinical relevance as biomarkers. We here provide a review of 116 pertinent articles from the last 10 years and describe the analytical methods, the matrices investigated, and the findings related to specific glycation biomarkers in relation to diagnosis or prognosis of disease-in particular diabetes and its complications, but also cardiovascular and renal diseases, as well as other conditions. Significant trends from the last decade are the diversification of applications beyond diabetes and its complications, an increasing number of innovative, noninvasive approaches to quantifying glycation biomarkers which seek to facilitate large-scale screening and early intervention, and the emergence of approaches combining several markers into a suite of analytes for assessment using Z-scores or machine learning algorithms.
- 15 November 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 566, 120036
Determination of glycation biomarkers in human fingernails by isotope-dilution liquid chromatography tandem mass spectrometry (LC-MS/MS)
- 15 November 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 566, 120036
Determination of glycation biomarkers in human fingernails by isotope-dilution liquid chromatography tandem mass spectrometry (LC-MS/MS)